AnaptysBio stock drops on malignancy concerns with Eli Lilly’s PD-1 agonist

Investing.comWednesday, September 17, 2025 at 12:31:02 PM
AnaptysBio stock drops on malignancy concerns with Eli Lilly’s PD-1 agonist
AnaptysBio's stock has taken a hit due to rising concerns over malignancy linked to Eli Lilly's PD-1 agonist. This news is significant as it raises questions about the safety of new cancer treatments, potentially impacting investor confidence and the future of similar therapies in development.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Lilly’s GLP-1 Pill Outperforms Older Novo Drug
PositiveFinancial Markets
Eli Lilly's new GLP-1 pill has shown promising results in a head-to-head trial against an older drug from Novo Nordisk, with patients experiencing greater weight loss and improved blood sugar control. This is significant as it highlights advancements in diabetes treatment options, potentially offering better health outcomes for patients struggling with this condition.
BMO Capital reiterates Outperform rating on Eli Lilly stock at $840 price target
PositiveFinancial Markets
BMO Capital has reaffirmed its Outperform rating on Eli Lilly's stock, setting a price target of $840. This endorsement reflects confidence in Eli Lilly's growth potential and market position, which is significant for investors looking for promising opportunities in the pharmaceutical sector.
Eli Lilly cautious on using FDA fast-track voucher for weight-loss pill
NeutralFinancial Markets
Eli Lilly has expressed caution regarding the use of a fast-track voucher from the FDA for its weight-loss pill. This decision is significant as it reflects the company's careful approach to regulatory processes, which could impact the speed at which the medication reaches consumers. The fast-track designation is designed to expedite the development of drugs that treat serious conditions, and Lilly's hesitance may indicate a desire to ensure thorough evaluation before proceeding.
Eli Lilly stock price target maintained at $825 by Cantor Fitzgerald
PositiveFinancial Markets
Eli Lilly's stock price target has been maintained at $825 by Cantor Fitzgerald, reflecting confidence in the company's growth and performance. This stability in target price is significant for investors as it suggests a strong outlook for Eli Lilly, especially in the context of ongoing developments in the pharmaceutical industry.
Berenberg downgrades Eli Lilly stock rating to Hold on plateauing obesity market
NegativeFinancial Markets
Berenberg has downgraded Eli Lilly's stock rating to 'Hold' due to concerns about a plateauing obesity market. This decision reflects the investment firm's belief that the growth potential in this sector may be stabilizing, which could impact Eli Lilly's future earnings. Investors should pay attention to this shift as it may signal a more cautious outlook for the company, especially given the increasing competition in the obesity treatment space.
Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs
PositiveFinancial Markets
Eli Lilly is set to invest $5 billion in a new plant in Virginia, a significant move for the pharmaceutical industry amid potential tariffs.
Editor’s Note: This investment is crucial as it not only boosts local employment but also strengthens the pharmaceutical sector's resilience against economic challenges like tariffs.
Latest from Financial Markets
From Loans to Jobs, Here’s How a Fed Rate Cut May Affect Your Wallet
PositiveFinancial Markets
The recent Federal Reserve rate cut is set to have a positive impact on various aspects of personal finance. Borrowers may find lower interest rates on loans, making it cheaper to finance purchases or consolidate debt. For those looking to buy or sell homes, the housing market could see increased activity as mortgage rates decline. Additionally, retirees and investors in the stock market might benefit from improved economic conditions, leading to better returns. Overall, this rate cut could stimulate economic growth and enhance financial well-being for many.
Top Bessent Aide, Daniel Katz, Expected to Be Tapped as No. 2 at I.M.F.
PositiveFinancial Markets
Daniel Katz, a key aide to Bessent, is anticipated to be appointed as the second-in-command at the International Monetary Fund (IMF). This move is significant as it reflects the IMF's commitment to strong leadership during challenging economic times, and Katz's expertise could play a crucial role in shaping global financial policies.
What the Fed’s Rate Decision Means for Loans, Credit Cards, Mortgages and More
NeutralFinancial Markets
The Federal Reserve's recent decision on interest rates has significant implications for loans, credit cards, and mortgages. By maintaining or adjusting rates, the Fed influences borrowing costs for consumers and businesses alike. This decision matters because it affects how much individuals pay for loans and credit, impacting their financial health and spending habits. Understanding these changes can help people make informed decisions about their finances.
KPMG Ignored Flaws at Regional Banks Before 2023 Crisis, Senate Report Finds
NegativeFinancial Markets
A recent Senate report reveals that KPMG overlooked significant flaws at regional banks prior to the 2023 crisis, raising serious concerns about the auditing industry's practices. Senator Richard Blumenthal emphasizes the urgent need for reform in the auditing sector to prevent future financial disasters. KPMG has dismissed the report as 'misguided,' but the findings highlight the critical role of effective auditing in maintaining financial stability.
JLR supply chain staff told to apply for universal credit, union claims
NegativeFinancial Markets
The Unite union has reported that staff at JLR are facing layoffs with reduced or zero pay due to a cyber attack that has led to a shutdown of operations. This situation is concerning as it highlights the vulnerabilities in supply chains and the impact of cyber threats on employment. The call for affected workers to apply for universal credit underscores the urgent need for support during this challenging time.
The Fed meeting brings together a Trump ally with a target of his ire.
NeutralFinancial Markets
The recent Federal Reserve meeting highlighted the complex dynamics between former President Trump and current Fed Chair Jerome Powell. As Trump has often criticized Powell's policies, this meeting serves as a significant moment for both figures, reflecting the ongoing tension between political influence and economic decision-making. Understanding these interactions is crucial as they can impact market stability and economic growth.